Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure that affects the left side of the heart. It occurs when the lower left chamber of the heart, called the left ventricle ...

New imaging tools, exercise testing, and phenotype-based therapy are reshaping how clinicians diagnose and treat HFpEF.

DEAR DR. ROACH: My husband is 73 and was diagnosed with heart failure and a severely dilated left ventricle. At the time, he was pumping 10 liters per minute. He had a proBNP natriuretic peptide level ...

Right ventricular dysfunction (RVD) is prevalent in 41.7% of patients with heart failure with preserved ejection fraction ...

Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been established in ...

The Exenatide Study of Cardiovascular Event Lowering (EXSCEL) evaluated the effects of once-weekly exenatide (EQW) in adults with type 2 diabetes mellitus (T2DM). Design, baseline characteristics, and ...

First, curiously, the primary outcome was all-cause mortality and not heart failure hospitalization, which is the most expected outcome in heart failure trials. Indeed, in many heart failure trials, ...

Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, ...

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR), according to a study ...